Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/05/2010US20100197626 Biomarkers for Depression and Methods Using the Same
08/05/2010US20100197625 Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders
08/05/2010US20100197624 Anthelmintic combination
08/05/2010US20100197623 Anti-Infammatory Macrolide
08/05/2010US20100197622 Non-Peptide Macrocyclic Histone Deacetylase (HDAC) Inhibitors and Methods of Making and Using Thereof
08/05/2010US20100197621 Methods of reducing the proliferation and viability of microbial agents
08/05/2010US20100197620 Pesticidal formulations
08/05/2010US20100197619 Cyclin-dependent protein kinases inhibitors of scutellaria flavonoid organic amine derivatives, synthesis and use thereof
08/05/2010US20100197618 Extract of rehmannia glutinasa libosch for reducing blood sugar, reducing blood fat, treating leukemia, and preparation method uses thereof
08/05/2010US20100197617 Process for the preparation of caralluma extract and a formulation prepared thereof
08/05/2010US20100197616 Proliferation inhibitor of helicobacter pylori including alpha-n-acetyl-glucosaminyl bond-containing monosaccharide derivatives
08/05/2010US20100197615 Synthesis of compounds useful as modulators of amyloid-beta production
08/05/2010US20100197614 Treatment of urinary tract infections with a mixture of saponin and an antibiotic
08/05/2010US20100197613 Methods for inhibition of nkt cells
08/05/2010US20100197612 Composition and Methods for the Treatment of Cancer
08/05/2010US20100197611 Alternative agent with vitamin d-like activity and an improving agent for intestinal function
08/05/2010US20100197610 Fructose 1, 6 bisphosphate - a novel anticonvulsant drug
08/05/2010US20100197609 Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010US20100197591 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197590 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197584 Use of curcumin to block brain tumor formation in mice
08/05/2010US20100197571 Extrudates with improved taste masking
08/05/2010US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics
08/05/2010US20100197566 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197563 Compositions and methods for altering elastogenesis
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196732 Method for providing fragrance to a substrate; fragrance-containing substrate
08/05/2010US20100196589 Room temperature stable agarose solutions
08/05/2010US20100196522 Compositions containing amines and use thereof
08/05/2010US20100196517 Topical delivery of a nitric oxide donor to improve body and skin appearance
08/05/2010US20100196516 Treatment of infections by carbon monoxide
08/05/2010US20100196513 Colon cleansing compositions and methods
08/05/2010US20100196510 Composition and treatment
08/05/2010US20100196509 Methods for Diagnosis and Treatment of Endometrial Cancer
08/05/2010US20100196507 Treatment of Wounds and Compositions Employed
08/05/2010US20100196504 Synergistic active preparations comprising 1,2-decanediol and further antimicrobial active compounds
08/05/2010US20100196502 Isoform Selective HDAC Inhibitors
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196493 Method for producing stable powder compositions
08/05/2010US20100196492 Electrostatic coating of particles for drug delivery
08/05/2010US20100196490 Compositions and methods of delivery of pharmacological agents
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196486 Methods for producing aripiprazole suspension and freeze-dried formulation
08/05/2010US20100196485 Rare earth metal compounds, methods of making, and methods of using the same
08/05/2010US20100196482 Polymer-encapsulated reverse micelles
08/05/2010US20100196481 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
08/05/2010US20100196479 METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
08/05/2010US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
08/05/2010US20100196475 Controlled release tablet formulation containing magnesium aluminometasilicate
08/05/2010US20100196474 Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
08/05/2010US20100196473 Pharmaceutical Composition Containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with Delayed Active Ingredient Release
08/05/2010US20100196472 Modified release compositions of milnacipran
08/05/2010US20100196471 Novel tablet dosage form
08/05/2010US20100196469 Pharmaceutical Formulation containing an HMG-COA Reductase Inhibitor and method for the preparation thereof
08/05/2010US20100196468 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
08/05/2010US20100196467 Therapeutic combination of amlodipine and benazepril/benazeprilat
08/05/2010US20100196466 Drug delivery system
08/05/2010US20100196465 Stable pharmaceutical composition of a water-soluble vinorelbine salt
08/05/2010US20100196464 Orlistat pharmaceutical formulations
08/05/2010US20100196463 Methods and compositions for reduction of side effects of therapeutic treatments
08/05/2010US20100196462 Method for Manufacturing a Pharmaceutical Form of Oseltamivir Phosphate
08/05/2010US20100196460 Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196457 Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
08/05/2010US20100196455 Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
08/05/2010US20100196454 Dressing formulations to prevent and reduce scarring
08/05/2010US20100196450 Targeting pax2 for the induction of defbi-mediated tumor immunity and cancer therapy
08/05/2010US20100196449 System and method to improve sensory function
08/05/2010US20100196447 Silk biomaterials and methods of use thereof
08/05/2010US20100196446 Drug delivery and substance transfer facilitated by nano-enhanced device having aligned carbon nanotubes protruding from device surface
08/05/2010US20100196443 Use of cordyceps species or extract thereof in the egg production
08/05/2010US20100196438 Methods including medical devices having a surface including a biologically active agent therein
08/05/2010US20100196437 Medical devices having a surface including a biologically active agent therein
08/05/2010US20100196436 Implants containing disulfiram and an anti-inflammatory agent
08/05/2010US20100196435 Materials and methods for delivering compositions to selected tissues
08/05/2010US20100196434 Combined fibnrinolytic and antimicrobial cathether and uses thetherof
08/05/2010US20100196427 Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
08/05/2010US20100196426 Use of microvesicles in diagnosis and prognosis of medical diseases and conditions
08/05/2010US20100196425 Oros push-stick for controlled delivery of active agents
08/05/2010US20100196424 Stabilization of long chain polyunsaturated oils
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196415 Process for purifying guar
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196401 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
08/05/2010US20100196400 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196396 Compositions and methods for modulating ghrelin-mediated conditions
08/05/2010US20100196394 Anti-cancer vaccine composition
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196387 Disulfide, Sulfide, Sulfoxide, and Sulfone Derivatives of Cyclic Sugars and Uses Thereof
08/05/2010US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors
08/05/2010US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
08/05/2010US20100196380 Babesia Subtilisin
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196377 Methods of treating, diagnosing or detecting cancer
08/05/2010US20100196369 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100196366 Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
08/05/2010US20100196365 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
1 ... 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 ... 7860